Journal of Dental Sciences
Volume 5, Issue 1 , Pages 30-35, March 2010

Enhancement of 5-aminolevulinic acid-induced photodynamic therapy by a bioadhesive polymer

  • Shu-Fang Chang

      Affiliations

    • Department of Dentistry, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
    • ,
  • Yu-Tsai Yang

      Affiliations

    • College of Oral Medicine, Taipei Medical University, Taipei, Taiwan
    • ,
  • Wei-Ling Li

      Affiliations

    • Graduate Institute of Biomedical Materials and Engineering, Taipei Medical University, Taipei, Taiwan
    • ,
  • Che-Tong Lin

      Affiliations

    • College of Oral Medicine, Taipei Medical University, Taipei, Taiwan
    • ,
  • Tsuimin Tsai

      Affiliations

    • College of Oral Medicine, Taipei Medical University, Taipei, Taiwan
    • Graduate Institute of Biomedical Materials and Engineering, Taipei Medical University, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Graduate Institute of Biomedical Materials and Engineering, Taipei Medical University, 250, Wu-Hsing Street, Taipei 11042, Taiwan

Received 14 November 2009; accepted 20 February 2010.

Article Outline

Background/Purpose

Using a topical formulation of 5-aminolevulinic acid (ALA), a mediated photodynamic therapy (PDT) was developed to treat oral precancerous and cancerous lesions. Several clinical results demonstrated that this special ALA preparation containing Carbopol 971P (CP971P), a bioadhesive polymer, resulted in a satisfactory PDT effect. It is believed that this PDT efficacy may be due to the increased bioadhesion of the preparation at the treatment site. We investigated whether there was a beneficial effect of CP971P on ALA PDT in vitro.

Materials and methods

CP971P was co-incubated with ALA in a cell culture system. The effect of CP971P was evaluated by monitoring the uptake of ALA, the fluorescence intensity of protoporphyrin IX, and the cell survival rate.

Results

The polymer was found to enhance the fluorescence intensity of protoporphyrin IX and the subsequent PDT effect when concurrently dosed with ALA.

Conclusion

Our results showed that a formulation of ALA containing C971P could provide a better ALA PDT effect in cancer treatment.

Key Words:  aminolevulinic acid , Carbopol , photodynamic therapy , protoporphyrin IX

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Malik Z , Lugaci H . Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins . Br J Cancer . 1987;56:589–595
  2. Divaris DX , Kennedy JC , Pottier RH . Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence . Am J Pathol . 1990;136:891–897
  3. Peng Q , Warloe T , Berg K , Moan J , Kongshaug M . 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges . Cancer . 1997;79:2282–2308
  4. Dolmans DE , Fukumura D , Jain RK . Photodynamic therapy for cancer . Nat Rev Cancer . 2003;3:380–387
  5. Henderson BW , Dougherty TJ . How does photodynamic therapy work? . Photochem Photobiol . 1992;55:145–157
  6. Hillemanns P , Weingandt H , Baumgartner R , Diebold J , Xiang W , Stepp H . Photodetection of cervical intraepithelial neoplasia using 5-aminolevulinic acid-induced porphyrin fluorescence . Cancer . 2000;88:2275–2282
  7. Levulan Kerastick (aminolevulinic acid HCl) for topical solution, 20% . Available at: http://www.icare.org/fda.htm
  8. Tsai JC , Chiang CP , Chen HM , et al.   Photodynamic therapy of oral dysplasia with topical 5-aminolevulinic acid and lightemitting diode array . Lasers Surg Med . 2004;34:18–24
  9. Chen HM , Chen CT , Yang H , et al.   Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy . Oral Oncol . 2004;40:630–637
  10. Yu CH , Chen HM , Hung HY , Cheng SJ , Tsai T , Chiang CP . Photodynamic therapy outcome for oral verrucous hyperplasia depends on the clinical appearance, size, color, epithelial dysplasia, and surface keratin thickness of the lesion . Oral Oncol . 2008;44:595–600
  11. Chien HF , Liao YH , Chen CT . Topical 5-aminolevulinic acid photodynamic therapy for warts . Lasers Surg Med . 2007;39(S19):57
  12. Wang YS , Tay YK , Kwok C , Tan E . Photodynamic therapy with 20% aminolevulinic acid for the treatment of recalcitrant viral warts in an Asian population . Int J Dermatol . 2007;46:1180–1184
  13. Duncan R . The dawning era of polymer therapeutics . Nat Rev Drug Discov . 2003;2:347–360
  14. Pharmaceutical Ingredients. Lubrizol Web site . http://www.lubrizol.com/Pharmaceutical/default.html
  15. Gerlier D , Thomasset N . Use of MTT colorimetric assay to measure cell activation . J Immunol Methods . 1986;94:57–63
  16. Gibson SL , Nguyen ML , Havens JJ , Barbarin A , Hilf R . Relationship of delta-aminolevulinic acid-induced protoporphyrin IX levels to mitochondrial content in neoplastic cells in vitro . Biochem Biophys Res Commun . 1999;265:315–321
  17. Masters JR . False cell lines: the problem and a solution . Cytotechnology . 2002;39:69–74
  18. Fuerte V , Maldonado M , Rees GD . The multicomponent automated dissolution system: an alternative in the development and pharmaceutical analysis of generic polydrugs . J Pharm Biomed Anal . 1999;21:267–272

PII: S1991-7902(10)60005-0

doi:10.1016/S1991-7902(10)60005-0

Journal of Dental Sciences
Volume 5, Issue 1 , Pages 30-35, March 2010

Article Tools